ESC 365 - The role of add-on therapies in the management of high and very high CV risk patients.

Open Access

The role of add-on therapies in the management of high and very high CV risk patients.

Session: Add on to take back control: Combining lipid lowering therapies for the management of high risk patients

Topic: Drug therapy

Speaker: Professor P. Perrone-Filardi (Napoly, IT)

Sponsored by Daiichi Sankyo Europe GmbH

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Professor Pasquale Perrone-Filardi

Federico II University Hospital, Napoly (Italy)

10 presentations

3 followers

4 more presentations in this session

Welcome and introduction.

Speaker: Professor J. Chapman (Paris, FR) Professor L. Tokgozoglu (Ankara, TR)

New guidelines: Importance to reduce LDL-C in patients at risk.

Speaker: Professor L. Masana (Reus, ES)

Novel options for the combination of LDL-C lowering therapies.

Speaker: Professor K. Ray (London, GB)

Live Q & A with chairmen & speakers.

Speaker: Professor L. Tokgozoglu (Ankara, TR) Professor J. Chapman (Paris, FR)

Access the full session

Add on to take back control: Combining lipid lowering therapies for the management of high risk patients

Speakers: Professor P. Perrone-Filardi, Professor J. Chapman, Professor L. Tokgozoglu, Professor L. Masana, Professor K. Ray...

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources